Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Intangibles (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Intangibles of $16.94 billion for Q3 2026, down 17.2% from $20.47 billion a year earlier and down 2.6% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Intangibles (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb posted Intangibles of $19.1 billion, down 18.0% from FY2024.

  • Intangibles has declined for six consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
  • By year, Intangibles came in at $23.31 billion in FY2024 (-13.9%), $27.07 billion in FY2023 (-24.5%), $35.86 billion in FY2022 (-15.7%) and $42.53 billion in FY2021 (-20.1%).
  • The Q3 2026 figure ranks as the lowest quarterly Intangibles since Q3 2019.
  • Year over year, Intangibles has now declined in each of the last 24 quarters, with an average decline of 21.2% over the last eight quarters.
  • Across the past five years, year-over-year decline in Intangibles ran from 2.4% in Q1 2024 to 31.4% in Q1 2025.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $17.39 billion (Q2 2026), $18.24 billion (Q1 2026) and $19.1 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 18.08 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 46.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 56.65 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 24.48 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 11.40 Bn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 38.15 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 19.54 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 13.42 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 45.96 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 16.94 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.94 Bn
Jun 30, 2026 17.39 Bn
Mar 31, 2026 18.24 Bn
Dec 31, 2025 19.10 Bn
Sep 30, 2025 20.47 Bn
Jun 30, 2025 21.38 Bn
Mar 31, 2025 22.49 Bn
Dec 31, 2024 23.31 Bn
Sep 30, 2024 26.96 Bn
Jun 30, 2024 29.43 Bn
Mar 31, 2024 32.76 Bn
Dec 31, 2023 27.07 Bn
Sep 30, 2023 28.95 Bn
Jun 30, 2023 31.30 Bn
Mar 31, 2023 33.57 Bn
Dec 31, 2022 35.86 Bn
Sep 30, 2022 38.18 Bn
Jun 30, 2022 37.69 Bn
Mar 31, 2022 40.10 Bn
Dec 31, 2021 42.53 Bn
API Access

Bristol Myers Squibb Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=BMY&period=max&api_key=YOUR_API_KEY